195 related articles for article (PubMed ID: 32521499)
1. Generation of two patient-derived iPSC lines from siblings (LIBUCi001-A and LIBUCi002-A) and a genetically modified iPSC line (JMUi001-A-1) to mimic dilated cardiomyopathy with ataxia (DCMA) caused by a homozygous DNAJC19 mutation.
Janz A; Chen R; Regensburger M; Ueda Y; Rost S; Klopocki E; Günther K; Edenhofer F; Duff HJ; Ergün S; Gerull B
Stem Cell Res; 2020 Jul; 46():101856. PubMed ID: 32521499
[TBL] [Abstract][Full Text] [Related]
2. Mutations in DNAJC19 cause altered mitochondrial structure and increased mitochondrial respiration in human iPSC-derived cardiomyocytes.
Janz A; Walz K; Cirnu A; Surjanto J; Urlaub D; Leskien M; Kohlhaas M; Nickel A; Brand T; Nose N; Wörsdörfer P; Wagner N; Higuchi T; Maack C; Dudek J; Lorenz K; Klopocki E; Ergün S; Duff HJ; Gerull B
Mol Metab; 2024 Jan; 79():101859. PubMed ID: 38142971
[TBL] [Abstract][Full Text] [Related]
3. Reversible Mitochondrial Fragmentation in iPSC-Derived Cardiomyocytes From Children With DCMA, a Mitochondrial Cardiomyopathy.
Rohani L; Machiraju P; Sabouny R; Meng G; Liu S; Zhao T; Iqbal F; Wang X; Ravandi A; Wu JC; Khan A; Shutt T; Rancourt D; Greenway SC
Can J Cardiol; 2020 Apr; 36(4):554-563. PubMed ID: 32046906
[TBL] [Abstract][Full Text] [Related]
4. CRISPR/Cas9-edited PKP2 knock-out (JMUi001-A-2) and DSG2 knock-out (JMUi001-A-3) iPSC lines as an isogenic human model system for arrhythmogenic cardiomyopathy (ACM).
Janz A; Zink M; Cirnu A; Hartleb A; Albrecht C; Rost S; Klopocki E; Günther K; Edenhofer F; Ergün S; Gerull B
Stem Cell Res; 2021 May; 53():102256. PubMed ID: 33640690
[TBL] [Abstract][Full Text] [Related]
5. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
[TBL] [Abstract][Full Text] [Related]
6. Generation of an iPSC line from a retinitis pigmentosa patient carrying a homozygous mutation in CERKL and a healthy sibling.
Bolinches-Amorós A; León M; Del Buey Furió V; Marfany G; Gonzàlez-Duarte R; Erceg S; Lukovic D
Stem Cell Res; 2019 Jul; 38():101455. PubMed ID: 31082679
[TBL] [Abstract][Full Text] [Related]
7. Generation of two iPSC lines (FAMRCi006-A and FAMRCi006-B) from patient with dilated cardiomyopathy and Emery-Dreifuss muscular dystrophy associated with genetic variant LMNAp.Arg527Pro.
Perepelina K; Klauzen P; Khudiakov A; Zlotina A; Fomicheva Y; Rudenko D; Gordeev M; Sergushichev A; Malashicheva A; Kostareva A
Stem Cell Res; 2020 Mar; 43():101714. PubMed ID: 32059175
[TBL] [Abstract][Full Text] [Related]
8. Novel homozygous pathogenic mitochondrial DNAJC19 variant in a patient with dilated cardiomyopathy and global developmental delay.
Al Tuwaijri A; Alyafee Y; Alharbi M; Ballow M; Aldrees M; Alam Q; Sleiman RA; Umair M; Alfadhel M
Mol Genet Genomic Med; 2022 Aug; 10(8):e1969. PubMed ID: 35611801
[TBL] [Abstract][Full Text] [Related]
9. Modeling of dilated cardiomyopathy by establishment of isogenic human iPSC lines carrying phospholamban C25T (R9C) mutation (UPITTi002-A-1) using CRISPR/Cas9 editing.
Barndt RJ; Ma N; Tang Y; Haugh MP; Alamri LS; Chan SY; Wu H
Stem Cell Res; 2021 Oct; 56():102544. PubMed ID: 34583280
[TBL] [Abstract][Full Text] [Related]
10. Generation and characterization of three human induced pluripotent stem cell lines (iPSC) from two family members with dilated cardiomyopathy and left ventricular noncompaction (DCM-LVNC) and one healthy heterozygote sibling.
Ben-Zvi H; Korover N; Rabinski T; Ofir R; Cohen S
Stem Cell Res; 2021 May; 53():102382. PubMed ID: 34088011
[TBL] [Abstract][Full Text] [Related]
11. Generation of patient-derived IPSC lines from a girl with Combined Oxidative Phosphorylation Deficiency 23 (COXPD23) caused by compound heterozygous GTPBP3 variants.
Wang C; Yuan C; Ji Z; Yin J; Zhang Z; Zhang H; Zheng B; Zhou W; Yang S
Stem Cell Res; 2022 May; 61():102775. PubMed ID: 35413567
[TBL] [Abstract][Full Text] [Related]
12. New mutation of mitochondrial DNAJC19 causing dilated and noncompaction cardiomyopathy, anemia, ataxia, and male genital anomalies.
Ojala T; Polinati P; Manninen T; Hiippala A; Rajantie J; Karikoski R; Suomalainen A; Tyni T
Pediatr Res; 2012 Oct; 72(4):432-7. PubMed ID: 22797137
[TBL] [Abstract][Full Text] [Related]
13. Generation of a homozygous DNAJC19 knockout human embryonic stem cell line by CRISPR/Cas9 system.
Chen G; Bai R; Huang P; Liu X; Ni J; Chen L
Stem Cell Res; 2024 Jun; 77():103427. PubMed ID: 38696852
[TBL] [Abstract][Full Text] [Related]
14. Mutation of DNAJC19, a human homologue of yeast inner mitochondrial membrane co-chaperones, causes DCMA syndrome, a novel autosomal recessive Barth syndrome-like condition.
Davey KM; Parboosingh JS; McLeod DR; Chan A; Casey R; Ferreira P; Snyder FF; Bridge PJ; Bernier FP
J Med Genet; 2006 May; 43(5):385-93. PubMed ID: 16055927
[TBL] [Abstract][Full Text] [Related]
15. Generation of genomic-integration-free human induced pluripotent stem cells and the derived cardiomyocytes of X-linked dilated cardiomyopathy from DMD gene mutation.
Zhu S; Law AHY; Deng R; Poon ENY; Lo CW; Kwong AKY; Liang R; Chan KYK; Wong WL; Tan-Un KC; Pijnappel WWMP; Chan GCF; Chan SHS
Stem Cell Res; 2020 Dec; 49():102040. PubMed ID: 33099108
[TBL] [Abstract][Full Text] [Related]
16. Previously Unreported Biallelic Mutation in DNAJC19: Are Sensorineural Hearing Loss and Basal Ganglia Lesions Additional Features of Dilated Cardiomyopathy and Ataxia (DCMA) Syndrome?
Ucar SK; Mayr JA; Feichtinger RG; Canda E; Çoker M; Wortmann SB
JIMD Rep; 2017; 35():39-45. PubMed ID: 27928778
[TBL] [Abstract][Full Text] [Related]
17. Generation of a heterozygous FLNC mutation-carrying human iPSC line, USFi002-A, for modeling dilated cardiomyopathy.
Argenziano MA; Burgos Angulo M; Najari Beidokhti M; Yang J; Bertalovitz AC; McDonald TV
Stem Cell Res; 2021 May; 53():102394. PubMed ID: 34088019
[TBL] [Abstract][Full Text] [Related]
18. Generation of two induced pluripotent stem cell lines from dilated cardiomyopathy patients carrying heterozygous FLNC mutations.
Kojic A; Kim H; Guevara JV; Ravada S; Sallam K; Wu JC
Stem Cell Res; 2022 Oct; 64():102928. PubMed ID: 36194907
[TBL] [Abstract][Full Text] [Related]
19. Generation of a patient-specific iPSC cell line with cardiac arrhythmias and dilated cardiomyopathy (CBRCULi016-A), an isogenic control (CBRCULi016-A-1), and a paternal control (CBRCULi017-A).
Djemai M; Jauvin D; Poulin H; Chapotte-Baldacci CA; Chahine M
Stem Cell Res; 2024 Mar; 75():103308. PubMed ID: 38232626
[TBL] [Abstract][Full Text] [Related]
20. Generation of a pluripotent stem cell line (UMGi270-A) and a corresponding CRISPR/Cas9 modified isogenic control (UMGi270-A-1) from a patient with sudden onset dilated cardiomyopathy harboring a FLNC p.R2187P mutation.
Maurer W; Rebs S; Köhne S; Eberl H; Wollnik B; Zibat A; Streckfuss-Bömeke K
Stem Cell Res; 2024 Jun; 77():103409. PubMed ID: 38583294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
